GS
ABMD

GAM Systematic’s Abiomed Inc ABMD Stock Holding History

GAM Systematic’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-344
Closed -$43K – 652
2017
Q1 		$43K Sell
344
-1,912
-85% -$222K 0.01% 564
2016
Q4 		$254K Buy
2,256
+1,253
+125% +$145K 0.06% 449
2016
Q3 		$129K Buy
+1,003
New +$120K 0.03% 535
2016
Q2 		– Sell
-969
Closed -$92K – 699
2016
Q1 		$92K Sell
969
-2,899
-75% -$245K 0.02% 533
2015
Q4 		$349K Sell
3,868
-288
-7% -$24.4K 0.1% 368
2015
Q3 		$386K Buy
+4,156
New +$366K 0.09% 405

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GAM Systematic's ABMD Position: Q2 2017 in Review

GAM Systematic sold out of Abiomed Inc (ABMD) in Q2 2017, closing a stake of 344 shares — an estimated $43K sold.

GAM Systematic first reported a position in ABMD in Q3 2015 and held it in 6 quarters. The position peaked at $386K in Q3 2015. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • GAM Systematic reported no remaining Abiomed Inc position as of Q2 2017 after selling out during the quarter.
  • GAM Systematic sold 344 Abiomed Inc shares in Q2 2017, an estimated $43K.
  • GAM Systematic first reported a position in Abiomed Inc in Q3 2015 and held it in 6 quarters.
  • GAM Systematic's Abiomed Inc position peaked at $386K in Q3 2015.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on GAM Systematic's 13F filing for Q2 2017, filed 14 Aug 2017.